Search research articles
Contact Us
Filters
Showing results (121-130 of 395) with videos related to
Page
of 40
Sort By:
Neuro-Degenerative Diseases
|
July 5, 2014
Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid
Erik Portelius, Hilkka Soininen, Ulf Andreasson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Gabriele Vilkaite, Lijun An, Yu Xiao, et al.
Journal of Alzheimer'S Disease : JAD
|
February 8, 2013
Plasma amyloid-β in patients with Tangier disease
Pashtun Shahim, Andrea E Bochem, Niklas Mattsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 15, 2019
Predicting diagnosis and cognition with <sup>18</sup>F-AV-1451 tau PET and structural MRI in Alzheimer's disease
Niklas Mattsson, Philip S Insel, Michael Donohue, et al.
Neurology
|
March 7, 2023
Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia
Eske Christiane Gertje, Shorena Janelidze, Danielle van Westen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 9, 2025
Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease
Ellen Hanna Singleton, Niklas Mattsson-Carlgren, Alexa Pichet Binette, et al.
Gait & Posture
|
February 1, 2022
Components of gait in people with and without mild cognitive impairment
Magnus Lindh-Rengifo, Stina B Jonasson, Susann Ullén, et al.
Psychoneuroendocrinology
|
November 20, 2012
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
Per Johansson, Erik G Almqvist, Jan-Ove Johansson, et al.
Brain : a Journal of Neurology
|
June 2, 2021
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
Joana B Pereira, Shorena Janelidze, Erik Stomrud, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 1, 2026
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
Isabelle Glans, Niklas Mattsson-Carlgren, Olof Strandberg, et al.
Page
of 40
Search research articles
Search
Showing results (121-130 of 395) with videos related to
Sort By:
Page
of 40
Neuro-Degenerative Diseases
|
July 5, 2014
Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid
Erik Portelius, Hilkka Soininen, Ulf Andreasson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Gabriele Vilkaite, Lijun An, Yu Xiao, et al.
Journal of Alzheimer'S Disease : JAD
|
February 8, 2013
Plasma amyloid-β in patients with Tangier disease
Pashtun Shahim, Andrea E Bochem, Niklas Mattsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 15, 2019
Predicting diagnosis and cognition with <sup>18</sup>F-AV-1451 tau PET and structural MRI in Alzheimer's disease
Niklas Mattsson, Philip S Insel, Michael Donohue, et al.
Neurology
|
March 7, 2023
Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia
Eske Christiane Gertje, Shorena Janelidze, Danielle van Westen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 9, 2025
Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease
Ellen Hanna Singleton, Niklas Mattsson-Carlgren, Alexa Pichet Binette, et al.
Gait & Posture
|
February 1, 2022
Components of gait in people with and without mild cognitive impairment
Magnus Lindh-Rengifo, Stina B Jonasson, Susann Ullén, et al.
Psychoneuroendocrinology
|
November 20, 2012
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
Per Johansson, Erik G Almqvist, Jan-Ove Johansson, et al.
Brain : a Journal of Neurology
|
June 2, 2021
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
Joana B Pereira, Shorena Janelidze, Erik Stomrud, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 1, 2026
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
Isabelle Glans, Niklas Mattsson-Carlgren, Olof Strandberg, et al.
Page
of 40